Novel Diagnostic kit for Mycobacterial Infections
The technology provides a PCR-based procedure for effective diagnose of Mycobacteria Other Than Tuberculosis (MOTT) infections directly from patient specimens in clinical testing. This method is far more superior to classical testing methods and biochemical tests. The technology uses a sequence of the internal transcribed spacer sequences (ITSS) of 16S-23S rDNA of mycobacteria to identify MOTT and distinguish them from Mycobacteria Tuberculosis (MTB). This novel method amplifies the rDNA of eleven different MOTT species in a single test and does not amplify M. tuberculosis DNA. This test can be applied directly on patient samples, both fresh and formalinfixed, which greatly decreases the turnaround time. Further objective of this technology is to provide test kits for determining whether a patient is infected with MOTT, MTB, or M. chelonae.
Sector: Pharmaceuticals
Country: India
Area of Application: Mycobacterial Infections,Mycobacteria
Keywords: Mycobacterial Infections
Advantages: The technology provides a more rapid (takes 24 hours) test for detecting and differentiating MOTT and MTB Gives rapid result (i.e. within 24 hours) It can diagnose several MOTT species in both fresh and archival tissue samples in a single test Cost-effective Eliminates the requirement for larger numbers of bacilli and is fit for both human and animal use Single test is needed
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054